1.In sarcopenia patients, the proto-oncogene serine/threonine-protein kinase PIM1 is the most markedly down-regulated gene. PIM1 kinase interacts with the DNA-binding domain of the vitamin D receptor and participates in the 25(OH)D3 signaling pathway. This evidence concerns the gene AKT1 and sarcopenia.